Biological E News Today

Us to deal with. And i love the way you two talked about whats happening and whats going to happen. Well, i mean, shes setting the tone for the administration. We have actually heard a lot from the new president in the past eight days. He has spoken publicly a lot. But we are hearing even more from jen psaki in the briefing room, and shes setting this tone of normalcy, accountability, Expository Work that tells us what the administration thinks the problem is, what they are doing to work on it, ...

PM Modi to meet seven Indian COVID-19 vaccine manufacturers on October 23 : Rashtra News #Modi #meet #Indian #COVID19 #vaccine #manufacturers #October Representatives from seven vaccine makers – Serum Institute of India, Bharat Biotech, Dr Reddy’s Laboratories, Zydus Cadila, Biological E, Gennova Biopharma and Panacea Biotech – will be participating in the meeting. Prime Minister

Biological E will scale up its production capacity to potentially reach 50 million doses annually

Biological E will scale up its production capacity to potentially reach 50 million doses annually, accelerating Takeda's efforts to manufacture 100 million doses annually within the decade

Japanese drug giant Takeda has partnered with Indian vaccine maker Biological E (BE) to manufacture its Dengue vaccine. BE will increase its manufacturing capacity to up to 50 million doses a year, supporting Takedas goal to produce 100 million doses annually by 2030. The collaboration leverages Takedas existing facility in Germany and its partnership with IDT Biologika GmbH.

India Business News: Takeda and Biological E Limited have partnered to manufacture up to 50 million doses per year of the dengue vaccine QDENGA, with the goal of deliverin

India Business News: Biological E's Covid-19 vaccine CORBEVAX has received emergency use listing from the World Health Organisation (WHO). The vaccine was approved in India for restricted use in emergency for adults, adolescents, and young children, as well as a heterologous booster dose for those aged 18 years and above. The Hyderabad-based vaccine maker has already supplied 100 million doses of CORBEVAX to the Indian government. The WHO EUL will help the company continue developing Covid-...

India News: Biological E's Covid vaccine, Corbevax, has received WHO emergency use listing, following approval in India. The vaccine, developed on the protein sub

Describing the murder of a 16-year-old girl by 23-year-old Sahil Khan as "premeditated" and "planned revenge", Delhi Police has filed a 640-page charg

Ranchi: A batch of 95 officials from police, child welfare committees and non-government organisations are undergoing training at the Investigation Tr.